Ernährung bei Gewichtsverlust – Vitalität stärken mit Genuss

Zusammenfassung

Es gibt zunehmend Evidenz, dass bei Krebspatient*innen während und nach der Krebstherapie einem zu starken Gewichtsverlust vorzubeugen ist. Welche Maßnahmen im Sinne der Sekundärprävention zu empfehlen sind, hängt stark vom Einzelfall und der vorliegenden Tumorerkrankung ab. Bei hormonabhängigen Tumoren, wie zum Beispiel Brustkrebs, ist bei adipösen Patientinnen nach erfolgter Primärtherapie eine Gewichtsreduktion sinnvoll. Unter stark belastenden Therapien und bei fortgeschrittener Tumorerkrankung hingegen sind die wichtigsten Ziele das Halten des Gewichts bzw. der Gewichtsaufbau. Gesundheitliche Beschwerden, die die Nahrungsaufnahme zusätzlich beeinträchtigen, sollten so früh wie möglich gelindert werden. Komplementärmedizinische Möglichkeiten werden anhand der Mukositis erläutert.

Abstract

There is an increasing evidence for preventing excessive weight loss in cancer patients during and after cancer therapy. Which measures are recommended in the sense of secondary prevention strongly depends on the individual case and the type of cancer. In hormone-dependent tumors, such as breast cancer in obese patients after successful primary therapy, a weight reduction makes sense. On the other hand, the most important goals are weight maintenance and weight gain under highly stressful therapies and advanced tumor disease. Side effects that additionally influence food intake should be alleviated as early as possible. Complementary medical options are explained on the basis of mucositis.

Schlüsselwörter

Ernährung - Gewichtsverlust - Kachexie - Mukositis - Chemotherapie - Nachsorge - komplementäre Therapien

Key words

Nutrition - weight loss - cachexia - mucositis - chemotherapy - aftercare - CAM

• Literatur

• 1 Arends J, Bertz H, Bischoff SC. et al. und das DGEM Steering Committee S3-Leitline der Deutschen Gesellschaft für Ernährungsmedizin e. V. (DGEM) in Kooperation mit der Deutschen Gesellschaft für Hämatologie und Onkologie e. V. (DGHO), der Arbeitsgemeinschaft „Supportive Maßnahmen in der Onkologie, Rehabilitation und Sozialmedizin“ der Deutschen Krebsgesellschaft (ASORS) und der Österreichischen Arbeitsgemeinschaft für klinische Ernährung (AKE). Aktuel Ernahrungsmed 2015; 40: e1-e74. doi:10.1055/s-0035-1552741
• 2 Azzouz A, Jurado-Sánchez B, Souhail B, Ballesteros E. Simultaneous determination of 20 pharmacologically active substances in cow's milk, goat’s milk, and human breast milk by gas chromatography-mass spectrometry. J Agric Food Chem 2011; 59: 5125-5132
• 3 Bihlmaier S. Tomatenrot und Drachengrün, immunstark und antikrebs-aktiv schlemmen. Weil der Stadt: Hädecke Verlag; 6. Aufl. 2018
• 4 Biswal BM, Zakaria A, Ahmad NM. Topical application of honey in the management of radiation mucositis: a preliminary study. Support Care Cancer 2003; 11: 242-248
• 5 Blauwhoff-Buskermolen S, Versteeg K, de van der Schueren M. et al. Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer. J Clin Oncol 2016; 34: 1339-1344
• 6 Bouvard V, Loomis D, Guyton KZ. et al. Carcinogenicity of consumption of red and processed meat. The Lancet 2015; 16: 1599-1600
• 7 Brinkman MT, Baglietto L, Krishnan K. et al. Consumption of animal products, their nutrient components and postmenopausal circulating steroid hormone concentrations. Eur J Clin Nutr 2010; 64: 176-183
• 8 Bruns F, Büntzel J, Mücke R. et al. Selenium in the treatment of head and neck lymphedema. Med Princ Pract 2004; 13: 185-190
• 9 Calle EE, Rodriguez C, Walker-Thurmond K. et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638
• 10 Charalambous A, Lambrinou E, Katodritis N. et al. The effectiveness of thyme honey for the management of treatment-induced xerostomia in head and neck cancer patients: A feasibility randomized controlled trial. Eur J Oncol Nurs 2017; 27: 1-8
• 11 Cerchietti LC, Navigante AH, Lutteral MA. et al. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2006; 65: 1330-1337
• 12 de A C Almeida R, de Sousa Lima FCM, do Vasconcelos EBC. Is bromelain an effective drug for the control of pain and inflammation associated with impacted third molar surgery? Systematic review and meta-analysis. Int J Oral Maxillofac Surg 2019; 48: 651-658
• 13 Demers M, Dagnault A, Desjardins J. A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation. Clin Nutr 2014; 33: 761-767
• 14 Deng G, Hou BL, Holodny AI, Cassileth BR. Functional magnetic resonance imaging (fMRI) changes and saliva production associated with acupuncture at LI-2 acupuncture point: a randomized controlled study. BMC Complement Altern Med 2008; 8: 37
• 15 Farlow DW, Xu X, Veenstra TD. Quantitative measurement of endogenous estrogen metabolites, risk-factors for development of breast cancer, in commercial milk products by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 1327-1334
• 16 Ganmaa D, Sato A. The possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers. Med Hypotheses 2005; 65: 1028-1037
• 17 Holzhauer P, Koula-Jenik H, Pempelfort K, Schneider B. Prophylaxe der Chemotherapie-assoziierten oralen Mukositis. Dtsch Z Onkol 2015; 47: 36-40
• 18 Hu J, La Vecchia C, Augustin LS. et al. Glycemic index, glycemic load and cancer risk. Ann Oncol 2013; 24: 245-251
• 19 Huang EY, Leung SW, Wang CJ. et al. Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial. Int J Radiat Oncol Biol Phys 2000; 46: 535-539
• 20 McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 2013; 39: 534-540
• 21 Meyerhardt JA, Sato K, Niedzwiecki D. et al. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst 2012; 104: 1702-1711
• 22 Mohsin AHB, Reddy SV, Kumar MP, Samee S. Aloe vera for dry mouth denture patients-palliative therapy. J Clin Diagn Res 2017; 11: ZC20-ZC23
• 23 Nagi R, Patil DJ, Rakesh N. et al. Natural agents in the management of oral mucositis in cancer patients – systematic review. J Oral Biol Craniofacial Res 2018; 8: 245-254
• 24 Oberbaum M, Yaniv I, Ben-Gal Y. et al. A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation. Cancer 2001; 92: 684-690
• 25 Pfister DG, Cassileth BR, Deng GE. et al. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. J Clin Oncol 2010; 28: 2565-2570
• 26 Pierce JP, Stefanick ML, Flatt SW. et al. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol 2007; 25: 2345-2351
• 27 Schiff E, Mogilner JG, Sella E. et al. Hypnosis for postradiation xerostomia in head and neck cancer patients: a pilot study. J Pain Symptom Manage 2009; 37: 1086-1092.e1
• 28 Unger C, Häring B, Kruse A. et al. Double-blind randomised placebo-controlled phase III study of an E. coli extract plus 5-fluorouracil versus 5-fluorouracil in patients with advanced colorectal cancer. Arzneim Forsch/Drug Res 2001; 51: 332-338